Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2001Leukemia & lymphoma/Leukemia and lymphoma

Lamivudine and Glycyrrhizin for Treatment of Chemotherapy-Induced Hepatitis B Virus (HBV) Hepatitis in a Chronic HBV Carrier with Non-Hodgkin Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

KMKeitaro MatsuoKanazawa UniversityKTKatsuto TakenakaHSHiroyuki ShimomuraJoslin Diabetes Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Matsuo et al. (2001) studied this question.

synapsesocial.com/papers/6a8579624f2eb4dbc91e5c74https://doi.org/10.3109/10428190109057970
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mutations in the Precore Region of Hepatitis B Virus DNA in Patients with Fulminant and Severe Hepatitis1991 · 532 citations
  2. 2Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation2000 · 72 citations
  3. 3Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial1999 · 181 citations
  4. 4EFFICACY AND SAFETY OF LAMIVUDINE ON REPLICATION OF RECURRENT HEPATITIS B AFTER CADAVERIC RENAL TRANSPLANTATION1997 · 111 citations
  5. 5Quantitative Detection of Hepatitis B Virus by Transcription-Mediated Amplification and Hybridization Protection Assay1999 · 90 citations